Next Article in Journal
New Models for the Study of Ocular Toxoplasmosis. Comment on Ashander et al. Human Retinal Organoid Model of Ocular Toxoplasmosis. Pathogens 2025, 14, 286
Previous Article in Journal
Pathological Features and Genotyping of Mycobacterium avium sub spp. paratuberculosis (MAP) in Small Ruminants in Saudi Arabia
Previous Article in Special Issue
Nutritional Stress Leads to Persistence and Persister-like Growth in Staphylococcus aureus
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Investigating the Sharing of Staphylococcus spp. Between Dogs and Their Owners: A Comparative Study from Two Italian Veterinary Teaching Hospitals

1
Department of Veterinary Medicine and Animal Production, University of Naples Federico II, 80137 Naples, Italy
2
Department of Veterinary Sciences, University of Turin, 10095 Turin, Italy
3
Task Force on Microbiome Studies, University of Naples Federico II, 80137 Naples, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Pathogens 2026, 15(4), 356; https://doi.org/10.3390/pathogens15040356 (registering DOI)
Submission received: 23 February 2026 / Revised: 21 March 2026 / Accepted: 25 March 2026 / Published: 27 March 2026

Abstract

Animal health is a key pillar of the One Health framework, which emphasizes the interconnectedness of humans, animals, and the environment. Staphylococcus spp., common commensals of skin and mucosa, are clinically important due to their virulence factors and increasing antimicrobial resistance. This cross-sectional study aimed to isolate and characterize Staphylococcus spp. from dogs and their owners and to assess correlations within their nasal microbiota. Nasal swabs were collected from at least 100 dog–owner pairs at two Veterinary Teaching Hospitals located in Northern (Turin Province) and Southern (Naples Province) Italy. In both study areas, S. pseudintermedius was the most common species in dogs. Among owners, S. epidermidis was predominant in Naples, while S. epidermidis and S. aureus were most frequent in Turin. A subset of 54 dog–owner pairs sharing the same Staphylococcus species (42 from Turin and 12 from Naples; in total 108 isolates) was included in this analysis, with a focus on antimicrobial patterns. S. aureus was the species most frequently shared between dogs and owners, followed by S. epidermidis, with no significant differences between the two sites. In particular, methicillin resistance (phenotypically inferred) was detected in 16.7% of isolates in Turin (19.0% in dogs; 14.3% in owners) and 41.7% of isolates in Naples (33.3% in dogs; 50.0% in owners). Multidrug resistance was detected in 34.3% of paired isolates overall, with a higher prevalence in Naples (58.3%) compared to Turin (27.4%). No significant association emerged between biofilm production and multidrug resistance (MDR). Overall, these findings suggest possible species sharing between dogs and owners, while biofilm formation did not predict MDR.

1. Introduction

Animal health is one of the pillars on which the One Health principle is based. The relationship between bacterial samples from dogs and their owners has become an increasingly important and widely discussed area of research in both microbiology and public health. As the recognition of the interconnectedness between human and animal health continues to grow, understanding how bacterial species, including pathogens, are shared between pets and their owners has significant implications for zoonotic disease transmission, antimicrobial resistance, and overall health management.
Recent studies support this perspective. For example, a 2024–2025 investigation identified a significant overlap in the gut microbiota of cohabiting human–dog pairs; specifically, 11 amplicon sequence variants (ASVs) were shared within these pairs, suggesting potential microbial exchange or similarity associated with cohabitation [1]. Similarly, new evidence shows that the ocular surface microbiomes of dogs and their owners exhibit increased similarity in households where they live together and that factors such as the size of the dog and the presence of other pets influence this sharing [2].
Moreover, the risk posed by antimicrobial-resistant bacteria shared between pets and humans has been underlined by genomic studies. A 2024 study using core genome multilocus sequence typing (cgMLST) documented cases of shared multidrug-resistant bacteria (e.g., resistant E. coli and vancomycin-resistant E. faecium) between dogs (and cats) and humans living in the same household, suggesting possible transmission or shared sources [3]. In a related manner, a 2024 study on dogs from diverse lifestyles (pet, rural, and stray) investigated their fecal microbiota and resistomes, reinforcing how environmental factors and lifestyle can shape the microbial and resistance profiles in dogs, with potential repercussions for health [4].
These findings align with the One Health approach by emphasizing the interconnectedness of humans, animals, and their environment. The evidence suggests that microbial sharing between pets and owners may have potential implications for public health. As this field of research evolves, further investigation is warranted to explore how these interactions might impact the prevention and control of infectious diseases that affect both species [5,6]. With the increasing number of companion animals in households, further study of these dynamics may provide valuable insights for strategies aimed at addressing emerging health threats in both animal and human populations.
Staphylococcus species are among the most common bacterial colonizers of both humans and companion animals, with prevalence on the skin, nasal mucosa, and other mucosal surfaces [7,8,9]. While many staphylococcal species function as commensals within the normal microbiota, several have the capacity to act as opportunistic pathogens, giving rise to infections when host defenses are compromised or microbial equilibrium is disrupted. In recent years, increasing attention has focused on the role of Staphylococcus aureus, Staphylococcus pseudintermedius, and related coagulase-negative staphylococci in the context of human–animal interactions, particularly within households where close contact facilitates bacterial sharing [10,11].
The emergence and dissemination of antimicrobial-resistant Staphylococcus strains including methicillin-resistant S. aureus (MRSA), methicillin-resistant S. pseudintermedius (MRSP), and multidrug-resistant coagulase-negative species represent a major challenge for both human and veterinary medicine. These bacteria frequently display resistance to multiple classes of commonly used antimicrobial agents, such as penicillins, cephalosporins, macrolides, lincosamides, and tetracyclines, limiting therapeutic options and increasing the complexity of clinical management. Recent studies in companion animals have documented high levels of multidrug resistance in both clinical and commensal isolates, with resistance profiles often involving several antibiotic classes simultaneously [7,12]. Additional work has confirmed that resistance to β-lactams, macrolides, and tetracyclines is widespread among Staphylococcus spp. that colonize dogs and cats, including healthy carriers [12], reflecting a broad and evolving resistance landscape.
Within the One Health framework, understanding the ecological and epidemiological dynamics of Staphylococcus spp. shared between humans and companion animals has become particularly relevant. Close physical contact between pets and their owners may facilitate cross-species transmission of both susceptible and resistant strains, contributing to the circulation of antimicrobial-resistant bacteria within households and potentially beyond [7,11]. Evidence of clonal relatedness between isolates from dogs and their owners reinforces the potential for interspecies bacterial exchange, particularly in settings characterized by frequent or prolonged human–animal interactions. These observations highlight the importance of integrated surveillance and coordinated antimicrobial stewardship strategies designed to protect the health of both humans and animals [13].
The aim of this study was to identify Staphylococcus species obtained from the nasal swabs of dogs and their owners at two Veterinary Teaching Hospitals in Italy, one located in Southern Italy (University of Naples) and the other in Northern Italy (University of Turin). Additionally, the antimicrobial resistance profiles of the isolated strains were analyzed. Special attention was given to cases in which the same Staphylococcus species was found in both the dog and its owner.

2. Materials and Methods

2.1. Ethical Statement

This study was approved by the Veterinary Service Center of the University of Naples Federico II (certificate number PG/2023/0120379) and by the Bioethics Committee of the University of Turin (certificate number 0251347), in compliance with Italian Legislative Decree 26/2014, Article 2, implementing Directive 2010/63/EU.
Nasal swab samples were collected from client-owned dogs undergoing routine surgical procedures at two Italian Veterinary Teaching Hospitals (University of Naples Federico II and University of Turin). Sample collection was performed by licensed veterinarians prior to surgery as part of standard clinical handling, causing minimal discomfort and no additional risk to the animals.
In accordance with the Declaration of Helsinki (1975, revised in 2013), nasal swab samples from dog owners were self-collected following written instructions provided by study personnel at the participating Italian universities and under supervision. No invasive procedures were performed, and sample collection did not involve any additional risk to the participants beyond routine personal hygiene practices.
Written informed consent was obtained from all participants prior to their inclusion in the study.

2.2. Study Design

A cross-sectional study involving dogs and their respective owners was performed at two Veterinary Teaching Hospitals (VTHs): VTH1 (University of Naples Federico II) located in Southern Italy and VTH2, University of Turin, located in Northern Italy. Subjects were enrolled at the time of the dogs’ admission for surgery. To ensure a clear geographical definition of the study populations, only dog–owner pairs residing in the same province as the recruiting hospital were eligible (Province of Naples for VTH1; Province of Turin for VTH2). Thus, the two study populations were defined at the provincial level, while enrollment was conducted at the corresponding referral hospitals. Upon arrival at the hospital and prior to sample collection, dog owners were provided with a written informed consent form. This included a brief questionnaire explaining the aim of the study, the procedures involved, and assurances regarding privacy and voluntary participation. After consent was obtained, paired nasal swabs were collected from each owner and their dog while the dog was under anesthesia and before the surgical procedure. Performing nasal swab sampling under these conditions minimized discomfort for the animals and facilitated the workflow of the veterinarians involved. The owners collected their own nasal swabs following the instructions provided. Participants who requested feedback received a summary of their individual results, including details of the Staphylococcus species identified in both the human and canine samples, as well as their antimicrobial resistance profiles.

2.3. Dog Owner Feedback Through Questionnaires

Dog–owner pairs were eligible for enrollment if they met the following criteria: (i) the dog’s admission to VTH1 or VTH2 during the study period and scheduling for elective or non-emergency surgical procedures; (ii) dogs of any breed or sex and aged ≥ 4 months; (iii) owner-reported residence within the Province of Naples (for VTH1) or within the Province of Turin (for VTH2); and (iv) provision of written informed consent and completion of a standardized questionnaire by the owner.
Pet owners were interviewed regarding their pet care practices and their relationship with their dogs. Specifically, the questionnaire was designed to collect information on the dog–owner relationship and close and prolonged contact behaviors with dogs that may facilitate the sharing of staphylococcal species and the dissemination of antimicrobial resistance determinants. The survey consisted of nine questions, each structured as multiple-choice items (2–4 response options), with the possibility of providing additional comments. The questions addressed the dog’s lifestyle and medical history, including any recent or previous antimicrobial treatments. A corresponding question regarding antimicrobial use was also included for the owners.

2.4. Sampling

This study was conducted between January 2024 and April 2025 at two sites: VTH1, Veterinary Teaching Hospital, University of Naples Federico II (Province of Naples, Campania Region, Southern Italy), and VTH2, Department of Veterinary Sciences, University of Turin (Province of Turin, Piedmont Region, Northern Italy). Sampling was performed on 120 dog–owner pairs at VTH1 and 160 dog–owner pairs at VTH2. Specimens consisted exclusively of non-invasive nasal swabs collected from dogs in the preoperative phase, primarily prior to orthopedic surgery. Nasal swabs were obtained from dogs while under sedation to minimize stress. Additionally, nasal swabs were collected from the dogs’ owners, who voluntarily agreed to participate in the study and performed the sampling themselves following the provided instructions. For each subject (both dog and owner), a single swab was inserted approximately 2–3 cm into each nostril, rotated 360° several times, and then placed in Stuart W/O CH transport medium (Aptaca S.p.A., Asti, Italy). All specimens were delivered to the respective microbiology laboratories for bacteriological analysis within a maximum of 2 h after collection.

2.5. Staphylococcus spp. Isolation and Identification

All samples were cultured on selective and differential agar media to isolate Staphylococcus spp. Mannitol salt agar (MSA) and Chromatic Staph aureus plates (Liofilchem srl, Teramo, Italy) were used and incubated aerobically at 37 °C for 24–48 h. Subsequently, the identification of the isolated strains was carried out by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) analysis (Bruker Daltonics, Bremen, Germany). The obtained spectra were compared with those in the Biotyper database, with a log(score) ≥ 2.0 being considered valid. A bacterial test standard (BTS) (Bruker Daltonics, Bremen, Germany) was used as a calibrator for quality control. Quality control was ensured using the reference strains S. pseudintermedius (ATCC 49444, TUCC 0347) and S. aureus (ATCC 33591, TUCC 01025). Pure isolated colonies were stored in tryptone soy broth with 15% glycerol at −80 °C for subsequent analyses.

2.6. Antimicrobial Susceptibility Profiles

Antimicrobial susceptibility testing for Staphylococcus spp. was conducted by the Disk Diffusion Test (DDT) according to the European Committee on Antimicrobial Susceptibility Testing [14]. The analysis was performed exclusively on staphylococcal isolates belonging to the same species recovered from both members of each dog–owner pair. This targeted approach was adopted to focus the investigation on phenotypic indicators of sharing within households, allowing for a direct comparison of resistance profiles in isolates showing species-level concordance.
The antimicrobial agents tested were grouped according to their categories [14,15] as follows: penicillins (penicillin, P, 10 IU); β-lactams for detection of meticillin resistance, including oxacillin (OX, 1 μg) and cefoxitin (FOX, 30 μg); macrolides and lincosamides, represented by erythromycin (E, 15 μg) and clindamycin (CD, 2 μg); fluoroquinolones, including ciprofloxacin (CIP, 5 μg) and enrofloxacin (ENR, 5 μg); aminoglycosides, represented by gentamicin (CN, 10 μg); tetracyclines, represented by tetracycline (TE, 30 μg); phenicols, represented by chloramphenicol (C, 30 μg); ansamycins, represented by rifampicin (RD, 30 μg); fusidanes, represented by fusidic acid (FA, 10 μg); folate pathway inhibitors, represented by sulfamethoxazole–trimethoprim (SXT, 23.75/1.25 μg); and oxazolidinones, represented by linezolid (LNZ, 30 μg). Antimicrobial susceptibility results were interpreted following EUCAST clinical breakpoints. Enrofloxacin, a veterinary drug, was interpreted using criteria for animals by the Clinical and Laboratory Standards Institute [16]. Specifically, detection of methicillin resistance differed depending on the species and the antibiotic used: cefoxitin disk diffusion was employed as the reference method for the detection of methicillin resistance in Staphylococcus aureus and in coagulase-negative staphylococci. In contrast, for Staphylococcus intermedius and S. pseudintermedius, oxacillin was used as the primary marker for methicillin resistance, as cefoxitin is not a reliable surrogate for mecA-mediated resistance in this species according to EUCAST [14] recommendations. Molecular confirmation of methicillin resistance genes (mecA or mecC) was not performed; therefore, methicillin resistance was inferred exclusively based on phenotypic susceptibility testing according to EUCAST recommendations.
Additionally, isolates were categorized as multidrug-resistant (MDR), extensively drug-resistant (XDR), or pandrug-resistant (PDR) strains following the criteria outlined by Magiorakos et al. [15]. Specifically, strains were considered MDR if they were resistant to at least one antimicrobial agent in three or more antibiotic categories, XDR if they were resistant to all but one or two categories (i.e., remaining susceptible to only one or two categories) and PDR if they showed resistance to all tested agents across all antibiotic categories.

2.7. Biofilm Formation Assay by Crystal Violet Staining

The biofilm-forming capacity of Staphylococcus spp. isolates was evaluated using the quantitative crystal violet assay following the protocol described by Stepanovic et al. [17], with slight modifications as previously detailed by Nocera et al. [18]. Specifically, overnight cultures were adjusted to an OD600 of 0.2 (≈108 CFU/mL) in fresh Brain Heart Infusion (BHI) broth (Liofilchem srl, Teramo, Italy). The standardized suspensions were then diluted at a ratio of 1:2 in 200 μL of BHI and transferred into sterile, flat-bottomed 96-well polystyrene microplates (Corning Inc., New York, NY, USA). Wells containing only 200 μL of BHI served as negative controls to confirm medium sterility and establish background absorbance levels. Microplates were incubated at 37 °C for 24 h, after which the contents were discarded and the wells were gently rinsed three times with sterile phosphate-buffered saline (PBS) to remove non-adherent cells, followed by air-drying. Biofilms attached to the well surfaces were stained with 200 μL of 1% crystal violet (BioMérieux, Marcy l’Etoile, France) for 30 min at room temperature. Excess stain was eliminated by washing with distilled water, and the retained dye was solubilized with 150 μL of 100% ethanol for 15 min at room temperature. Absorbance was measured at 570 nm using a Multiskan FC microplate reader (Thermo Fisher Scientific, Milan, Italy). All assays were performed in triplicate and repeated on three independent occasions.
Biofilm production was interpreted according to the criteria by Stepanovic et al. [17] by comparing each isolate’s mean OD with the negative control and the cutoff value (ODc). Based on these parameters, isolates were categorized as:
  • No biofilm formation: OD ≤ ODc;
  • Weak biofilm formation: ODc < OD ≤ 2 × ODc;
  • Moderate biofilm formation: 2 × ODc < OD ≤ 4 × ODc;
  • Strong biofilm formation: OD > 4 × ODc.

2.8. Data Analysis

The difference in the frequency of questionnaire answers, Staphylococcus spp. proportions between the two different Veterinary Teaching Hospitals, and the antibiotic resistance between the two VTHs and dogs and owners were investigated using Fisher’s exact test. For analyses involving multiple comparisons on the same samples, p-values were adjusted using the Benjamini–Hochberg procedure to control the false discovery rate. Logistic regression models were used to evaluate the association between questionnaire variables and the detection of shared Staphylococcus species in dog–owner pairs. Variables were initially screened through univariate analyses, and those with p < 0.20 were considered for inclusion in the multivariate model. To reduce the risk of overfitting, the number of predictors included in the final model was guided by the events-per-variable (EPV) criterion, ensuring an EPV value > 10. Collinearity among predictors was assessed using the variance inflation factor (VIF). Manual backward stepwise selection was applied to define the final model, which was guided by a combination of statistical and biological considerations. Changes in model deviance and likelihood ratio tests were used to compare nested models, ensuring that exclusion of variables improved model fit and that the results were consistent across alternative model specifications. Model selection was further supported by an evaluation of the information criteria (AIC). Model performance was evaluated by assessing the goodness of fit using the Hosmer–Lemeshow test; model discrimination was determined using the area under the receiver operating characteristic curve (AUC), and explanatory power was obtained using Nagelkerke’s pseudo-R2. A threshold of 0.05 was used to guide the interpretation of statistical differences. Statistical analyses were conducted in the R statistical environment (version 4.4.3) [19]. Logistic regression models were fitted using the package lme4 (version 1.1-36). Fisher’s exact tests performed within the Naples study group were calculated using the Easy Fisher Exact Test Calculator (www.socscistatistics.com accessed on 10 November 2025) web tool.

3. Results

3.1. Survey Data Collected from Dog Owners

More than 100 questionnaires were completed at each hospital, with a total of 120 questionnaires collected at VTH1 (Naples Province) and 160 at VTH2 (Turin Province). The response rates to individual questions are summarized in Table 1. In Naples Province, most animals lived exclusively indoors (56.7%), similar to those in Turin (50.0%). However, dogs living in Naples Province were more frequently confined to the garden compared to dogs from the Province of Turin (p = 0.023), which more frequently had access to both outdoor and indoor areas (p = 0.048). The dogs’ access to a personal resting place, including beds and sofas, was reported at comparable rates in Naples and Turin.
Regarding antiparasitic treatments, owners in the Province of Turin reported a lower overall frequency of administration. A higher proportion declared never using antiparasitic treatments, and flea and tick control was less frequently reported in Turin compared with the Province of Naples (p = 0.043). Also, constant and/or intermittent use was more common in Naples, whereas seasonal administration predominated in Turin (p < 0.001).
Regarding feeding habits, commercial diets were the most frequently reported in both Naples (54.2%) and Turin Provinces (61.9%), while homemade diets were relatively uncommon in both areas (12.5% and 10.0%, respectively).
Analysis of the collected data on close physical interactions showed that most owners in both Naples (75%) and Turin (80%) reported a close relationship with their pets, which was characterized by cuddling, hugging, and kissing. Hand hygiene practices after contact with pets were comparable between the two provinces, with “sometimes” being the most frequently reported response, followed by “always” and “never.” All-day interaction with pets was reported at similar rates in Turin (44.4%) and Naples (37.5%), while half-day interaction showed modest non-significant differences, being more common in Naples (49.2%) than in Turin (37.5%).
Regarding antibiotic therapy in pets, recent antibiotic use was similar between provinces, whereas dogs from the Province of Turin were more frequently reported as never having received antibiotics and less frequently as treated in the past (p < 0.001). Conversely, no differences were observed for the owners.
The final logistic regression model included owner gender, dog sex, and frequency of handwashing after contact with the dog. Male owners were associated with lower odds of sharing Staphylococcus spp. with their dogs (OR = 0.37, 95% CI: 0.16–0.82, p = 0.017). Neutered male dogs were associated with higher odds of shared colonization (OR = 4.23, 95% CI: 1.08–18.99, p = 0.045), although with limited precision. Similarly, owners who reported always washing their hands after contact with their dogs were associated with increased odds of sharing the same Staphylococcus species (OR = 10.33, 95% CI: 1.69–201.50, p = 0.035), although the wide confidence interval indicates substantial uncertainty in the magnitude of the effect.
Model performance was evaluated in terms of goodness of fit, discrimination, and explanatory power. The Hosmer–Lemeshow test did not indicate a lack of fit (p = 0.899), suggesting adequate agreement between the observed and predicted values. The model showed acceptable discrimination, with an area under the receiver operating characteristic curve (AUC) of 0.699. The explanatory power of the model was limited, as indicated by a Nagelkerke’s pseudo-R2 of 0.143. Considering the number of estimated parameters in the model, the events-per-variable (EPV) ratio was slightly below the conventional threshold of 10, indicating a potential risk of overfitting. This may have contributed to the limited precision and wide confidence intervals observed for some predictors.

3.2. Identification of Staphylococcus spp. and Species Distribution

A total of 477 Staphylococcus strains were recovered from nasal swabs of dogs and their owners attending the two Veterinary Teaching Hospitals (Table 2). Overall, S. epidermidis was the most frequently identified species (142/477; 29.8%), followed by S. aureus (106/477; 22.2%) and S. pseudintermedius (61/477; 12.8%). All other species were detected at lower frequencies (<7.0%).
Among dogs from Naples Province (VTH1; n = 73 isolates), S. pseudintermedius was the predominant species (26/73; 35.6%), followed by S. aureus (12/73; 16.4%) and S. epidermidis (7/73; 9.6%). Other species were detected at lower frequencies, including S. warneri (5.5%), S. felis (5.5%), and S. simulans (5.5%).
Similarly, in dogs from Turin Province (VTH2; n = 130 isolates), S. pseudintermedius was the most frequently isolated species (31/130; 23.8%), followed by S. aureus (21/130; 16.2%) and S. intermedius (15/130; 11.5%). As expected, owners showed a predominance of human-associated coagulase-negative staphylococci. Among owners from Naples Province (VTH1; n = 86 isolates), S. epidermidis was the most prevalent species (53/86; 61.6%), followed by S. aureus (27/86; 31.4%). No isolates of S. pseudintermedius were detected in this group.
Among owners from Turin Province (VTH2; n = 188 isolates), S. epidermidis remained the most frequent species (74/188; 39.4%), followed by S. aureus (46/188; 24.5%). Low percentages of S. pseudintermedius were detected in this group (4/188; 2.1%). Other species identified in owners included S. warneri (9.0%), S. capitis (8.5%), and S. haemolyticus (4.8%).
Overall, a clear host-related pattern emerged in both provinces: S. pseudintermedius predominated in dogs, whereas S. epidermidis was the dominant species in owners. The relative distribution of the two most clinically relevant species, S. aureus and S. pseudintermedius, was broadly comparable between Naples and Turin in dogs, while owners from Naples showed a higher proportion of S. epidermidis compared with those from Turin.
To investigate the potential sharing of Staphylococcus spp., species concordance was evaluated in matched dog–owner pairs from both study provinces.
Concordant species (isolation of the same Staphylococcus species in both dogs and owners) were identified in 54/280 dog–owner pairs (19.2%) overall. When subdivided by province, concordance was observed in 12/120 dog–owner pairs (10%) in Naples and in 42/160 dog–owner pairs (26.3%) in Turin Province (p = 0.001).
The remaining dog–owner pairs (226/280; 80.7%) showed discordant species profiles, defined as isolation of different Staphylococcus species in the dog and the corresponding owner.
Among concordant dog–owner pairs, the most frequently shared species was S. aureus, which was detected in 6/12 dog–owner pairs (50.0%) in the Province of Naples and 11/42 dog–owner pairs (26.2%) in the Province of Turin. S. epidermidis represented the second most common shared species, accounting for 5/12 pairs (41.7%) in Naples and 9/42 dog–owner pairs (21.4%) in Turin. S. warneri was also identified among concordant dog–owner pairs, with 1/12 dog–owner pairs (8.3%) in Naples and 7/42 dog–owner pairs (16.7%) in Turin. S. pseudintermedius/intermedius was identified as a shared species only in Turin Province (6/42 dog–owner pairs; 14.3%) overall. Other species were rarely involved in concordant colonization events and were detected only sporadically.

3.3. Antimicrobial Resistance Profiles

The antimicrobial resistance analysis was performed exclusively on the subset of 54 same-species dog–owner pairs (108 isolates) selected for pairwise comparison. Consequently, the resistance profiles reported here should be interpreted with caution and not as representative of the overall resistance prevalence among all isolates collected in the study. Resistance to at least one antimicrobial agent was detected in 94/108 isolates (87.0%) from the same-species dog–owner pairs. The proportion of resistant isolates was comparable between sites, accounting for 22/24 isolates (91.6%) in Naples and 72/84 isolates (85.7%) in Turin (p = 0.731).
In Naples, higher proportions of resistance to penicillin, fusidic acid, ciprofloxacin, clindamycin, enrofloxacin, erythromycin, and chloramphenicol, as well as a higher frequency of MRS strains, were observed in human-derived Staphylococcus spp. compared with canine isolates (Figure 1); however, these differences were not statistically significant.
Similarly, in Turin, higher resistance percentages in human-origin isolates were observed for penicillin, clindamycin, erythromycin, sulfamethoxazole–trimethoprim, and linezolid, as well as a higher proportion of MRS compared with those of canine origin. Also in this case, the differences were not statistically significant (Figure 2).
Overall, multidrug resistance (MDR) was observed in 37/108 isolates (34.3%). In Naples Province, MDR was detected in 5/12 (41.7%) dogs and 8/12 (66.7%) owners. MDR was more common in Naples than Turin (13/24, 54.2% vs. 24/84, 28.6%), and within each site, it was detected more frequently among owner isolates than dog isolates (Naples: 8/12 vs. 5/12; Turin: 13/42 vs. 11/42). The difference between provinces was statistically significant (p = 0.028), but no statistical significance was observed for different MDR categories between dogs and owners. No XDR or PDR phenotypes were detected among the isolates analyzed.

3.4. Methicillin Resistance Patterns

Methicillin resistance was assessed phenotypically according to EUCAST (2025) recommendations, using oxacillin or cefoxitin disk diffusion, with positive results of both tests indicative of penicillin-binding protein 2a (PBP2a)-mediated resistance. Resistant isolates were detected in both study areas, although with different prevalence rates and patterns of host distribution.
In the Province of Naples (Table 3a), methicillin resistance was detected in 11 of 24 isolates (45.8%). Considering host origin, resistant isolates were identified in 5 of 12 dogs (41.7%) and 6 of 12 owners (50%) (Table 3a, Figure 1). Concordant methicillin resistance profiles were observed in seven pairs (58.3%), while five pairs (41.7%) showed discordant profiles.
In the Province of Turin (Table 3b), methicillin resistance was detected in 14 of 84 isolates (16.7%) and occurred in 8 of 42 (14.3%) owner isolates and 6 of 42 (19%) dog isolates (Table 3b and Figure 2). A high level of concordance was observed, with 38 of 42 dog–owner pairs (90.5%) showing concordant methicillin resistance phenotypes and only four dog–owner pairs (9.5%) displaying discordance.
Overall, these findings indicate a higher prevalence of phenotypically methicillin-resistant staphylococci in Naples than in Turin (p = 0.035) and highlight differences in host distribution and species concordance in dog–owner pairs between the two study sites.
When considering resistance markers at the couple level in both provinces, penicillin resistance, used as a phenotypic indicator of penicillinase production, was prevalent, being detected in 32/54 dog–owner pairs (59.3%). In contrast, resistance to oxacillin or cefoxitin, reliable phenotypic predictors of methicillin resistance, was less frequently observed (9/54, 16.7%). Specifically, methicillin resistance profiles were identified in 4 of 12 dog–owner pairs (33.3%) in Naples, whereas in Turin, such profiles were detected in 5 of 42 dog–owner pairs (11.9%).
Furthermore, dog–owner pairs in which both members carried multidrug-resistant (MDR) staphylococci were detected in 3 out of 12 pairs (25%) in Naples, and in 7 out of 42 dog–owner pairs (16.7%) in Turin, showing no statistically significant difference. In addition, identical phenotypic profiles, defined by the same penicillin, oxacillin or cefoxitin resistance pattern, MDR status, and biofilm production type, were observed in 4 out of 12 dog–owner pairs (33.3%) in Naples and in 3 out of 42 dog–owner pairs (7.1%) in Turin, representing a statistically significant difference (p = 0.002) (Table 3a,b and Table S1a,b). In Naples, when phenotypes were aggregated by host (Table 3a), penicillinase production was more frequently observed among owners (10/12, 83.3%) than dogs (9/12, 75%). Equally, methicillin resistance showed a slightly higher frequency in owners (6/12, 50%) than in dogs (5/12, 41,7%). Multidrug resistance was more common in owners (8/12, 66.7%) compared to dogs (5/12, 41.7%). In Turin (Table 3b), penicillinase production was observed with comparable frequencies in dogs (31/42, 73.8%) and owners (32/42, 76.2%). Similarly, methicillin resistance showed only marginal differences between the two groups, being detected in 6/42 dogs (14.3%) and 8/42 owners (19.0%). Multidrug resistance was higher in owners (13/42, 31%) than in dogs (11/42, 26.2%), although the overall prevalence remained moderate in both populations.

3.5. Biofilm Formation Ability

The assessment of biofilm-forming capacity demonstrated that, in Naples, only two dog–owner pairs exhibited discordant biofilm production. In these cases, S. epidermidis isolates from dogs and their respective owners were classified as moderate biofilm producers when they were of canine origin and as weak producers when they were of human origin (Figure 3). In Turin, 24 out of 42 pairs displayed concordant biofilm-forming capacity (Figure 4).
In Naples, most of the isolates related to the selected dog–owner pairs, specifically 22 out of 24, were moderate biofilm producers, while the remaining two strains were weak biofilm producers (Table 3a). In any case, we found no association between biofilm-forming ability and MDR profiles (p = 0.482): among isolates with moderate biofilm-forming ability (n = 22), 11 were MDR, while 11 were non-MDR.
In Turin, we detected 33 strong biofilm-producing strains, 11 of which also showed an MDR profile (Table 3b). The two groups did not differ significantly, indicating no correlation between strong biofilm-forming ability and MDR profiles (p = 1.000).

4. Discussion

The present study investigated the distribution, antimicrobial resistance profiles, and biofilm-forming ability of Staphylococcus spp. isolated from dog–owner pairs in two geographically distinct Italian areas, with a specific focus on species concordance.
The genus Staphylococcus comprises more than 50 species and 24 subspecies and is known for its ability to survive a broad range of adverse environmental conditions, including extreme temperatures, dehydration, and low water activity [20,21]. Within the “One Health” framework, staphylococci are of particular concern because they colonize both humans and animals and can act as reservoirs for antimicrobial resistance genes with potential for interspecies transmission [22].
Overall, the species distribution observed in the present study was consistent with the expected host-specific ecological niches of staphylococci. In both geographical areas, S. pseudintermedius was the predominant species isolated from dogs, confirming its well-recognized role as the primary canine commensal and opportunistic pathogen [23]. Conversely, among owners, coagulase-negative staphylococci, particularly S. epidermidis, were highly prevalent, especially in Naples, while both S. epidermidis and S. aureus were frequently detected in Turin. This distribution is consistent with previous reports indicating that S. epidermidis represents one of the most common colonizers of the human nasal mucosa [24], whereas S. aureus maintains a stable carriage rate in a substantial proportion of healthy individuals [25]. Both S. aureus and S. epidermidis are especially significant due to their involvement in infections ranging from mild skin lesions to severe, invasive diseases such as bacteremia, endocarditis, and device-associated infections [26,27]. In addition, S. aureus and S. epidermidis represented the most frequently shared species between dogs and owners in concordant pairs, with no significant difference observed between the two study populations. The frequent detection of S. aureus and S. epidermidis in concordant dog–owner pairs may reflect shared exposure or co-colonization within the household environment rather than direct transmission, particularly because strain-level typing was not performed in the present study. Previous research has shown host-specific colonization preferences and a higher adhesion capacity of S. aureus to human epithelial cells [28,29], which may partly explain the predominance of human-associated species observed among owners. However, the cross-sectional design of this study does not allow conclusions regarding the directionality or mechanisms underlying the observed species concordance. Studies using molecular typing approaches have demonstrated that genetically related staphylococcal strains can occasionally be identified in dogs and their owners living in the same household [28,30], supporting the possibility of bacterial sharing or exposure to common sources. Similarly, epidemiological investigations conducted in Italy have reported overlapping S. aureus and S. epidermidis strains in dogs and their owners, suggesting that close human–animal contact may facilitate microbial exchange within domestic environments [7]. Nevertheless, confirmation of strain-level relatedness would require molecular or genomic analyses, which were beyond the scope of the present study.
Although differences in pet management practices were observed between the Naples and Turin populations, these variables were not associated with the occurrence of species concordance within dog–owner pairs. The associations observed between potential sharing and owner gender, dog sex, and handwashing practices should be interpreted with caution. While male owners appeared less likely to share Staphylococcus spp. with their dogs, gender-related behavioral differences in daily pet interaction patterns (e.g., close contact, caregiving role, and duration of physical interaction) may partially explain this finding. The associations observed for neutered male dogs and for handwashing practices are difficult to interpret and may reflect unmeasured confounding or behavioral patterns not captured by the questionnaire. Importantly, the wide confidence intervals, particularly for the handwashing variable (95% CI: 1.69–201.50), indicate limited precision of the estimated effects and suggest a degree of model uncertainty, likely related to the relatively small number of observations in some exposure categories. In addition, the overall explanatory power of the model was modest, reflecting the multifactorial nature of the investigated outcome. Taken together, these findings should be considered exploratory and hypothesis-generating rather than indicative of causal relationship.
The absence of differences in antimicrobial resistance profiles between canine and human isolates within shared species is consistent with potential strain sharing, although molecular confirmation at strain-level was beyond the scope of this study. In contrast, some differences were observed between the two geographical areas, namely higher resistance to chloramphenicol and tetracycline and an increased frequency of phenotypically methicillin-resistant isolates detected in Naples. While the lack of molecular screening for mecA and mecC genes for the characterization of methicillin resistance mechanisms represents a limitation of this study, these phenotypic findings may reflect regional variability in antimicrobial exposure or the circulation of local strains rather than host-specific selective pressures. MDR isolates were detected in both geographical areas, with no significant differences in their frequency between locations. The overall MDR proportion remained moderate, supporting the hypothesis that community-associated staphylococcal populations are not yet characterized by widespread high-level resistance. In our study, no isolates fulfilled the criteria for the XDR or PDR phenotypes, indicating that, despite the detection of multidrug resistance, extreme resistance profiles remain uncommon in this community-based population.
A key element of staphylococci’s persistence and pathogenicity is the biofilm-forming ability [31], which greatly enhances bacterial survival under hostile conditions, including exposure to antimicrobial agents and host immune defenses [32], and leads to higher rates of treatment failure and frequent recurrence [33,34]. Evidence suggests that biofilm producers often exhibit elevated antimicrobial resistance, either through specific genetic determinants or through the intrinsic protective properties of the biofilm matrix [35,36]. Specifically, MRSA often displays enhanced biofilm-forming capacity, which further complicates therapeutic management [37,38]. Understanding these traits is essential when evaluating the potential sharing of Staphylococcus spp. between dogs and their owners, as biofilm-associated and resistant strains may be more capable of persisting and disseminating across species barriers. However, in this study, no association was detected between biofilm production and multidrug resistance in either study population. While these results should be interpreted with caution due to the limited number of isolates available for this specific analysis, these findings are consistent with several previous studies reporting no clear relationship between biofilm-forming ability and antimicrobial resistance in Staphylococcus populations [39,40,41] and support the theory that the relationship between biofilm biomass and antimicrobial susceptibility is highly variable and is influenced by species, strain-specific traits, type of antibiotic, and methodological approaches [42]. Another plausible explanation is the predominance of commensal rather than clinical isolates in this study; the isolates we examined likely represent saprophytic populations of the nasal mucosa in both dogs and humans, which may experience a different evolutionary drive to develop multidrug resistance or enhanced biofilm formation.
Several limitations should be considered when interpreting these findings. The cross-sectional design of this study prevents assessment of temporal dynamics or the directionality of bacterial sharing between hosts. Although bacterial identification was performed at the species level using MALDI-TOF MS, the absence of molecular typing methods, such as MLST, spa typing, or whole-genome sequencing, precluded determination of strain-level relatedness between isolates. Similarly, methicillin resistance was inferred from phenotypic profiles without molecular confirmation of mec genes. It should also be noted that evaluation of antimicrobial resistance was restricted to isolates from concordant dog–owner pairs to better investigate phenotypic indicators of sharing. While this focus addressed this study’s primary objective, it introduced selection bias; consequently, the reported resistance frequencies may not reflect the broader staphylococcal population but are instead specifically representative of isolates involved in species-level concordance. Regarding the study population, recruitment of dogs from referral Veterinary Teaching Hospitals and reliance on convenience sampling may limit the generalizability of the findings to broader canine and human populations. While the sample size may appear modest, it reflects the practical challenges of recruiting dog–owner pairs for nasal swab collection, a procedure often perceived as uncomfortable, particularly in the post-pandemic context. Consequently, the reported frequencies should not be interpreted as prevalence estimates or assumed to be fully representative of the broader population.
A comprehensive One Health investigation would ideally include environmental sampling; however, domestic environments shared by dogs and owners are highly heterogeneous, making standardized and reproducible sampling logistically challenging. Finally, the lack of molecular or genomic typing prevents confirmation of species concordance at the strain level between dogs and owners. Future studies incorporating molecular or genomic approaches will be essential to better characterize the transmission dynamics suggested by these findings.

5. Conclusions

The identification of shared Staphylococcus spp., particularly S. aureus and S. epidermidis, in dogs and their owners supports the occurrence of species concordance and potential microbial sharing within households. The absence of differences in antimicrobial resistance profiles between human- and animal-origin isolates, together with the predominance of human-associated species, is consistent with the presence of a shared ecological niche of commensal staphylococci at the human–dog interface. In addition, no significant association emerged between biofilm-forming ability and multidrug resistance. Overall, these findings highlight the complexity of staphylococcal ecology within households and suggest that microbial sharing between dogs and owners may reflect stable co-colonization dynamics rather than simple transmission events. A more comprehensive One Health approach, potentially including environmental sampling and strain-level characterization, would be necessary to better understand these interactions.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/pathogens15040356/s1, Table S1: (a) Phenotypic indicators of penicillinase production, mecA-mediated methicillin resistance, multidrug resistance (MDR), and biofilm-forming ability among paired Staphylococcus isolates from dogs and owners in the Province of Naples (Southern Italy). (b) Phenotypic indicators of penicillinase production, mecA-mediated methicillin resistance, and multidrug resistance (MDR) among paired Staphylococcus isolates from dogs and owners (Turin Province, Northern Italy).

Author Contributions

Conceptualization, L.D.M. and P.N.; methodology, F.P.N., P.R., R.S., S.C., A.B., I.P., D.M., A.R., S.A., G.I., M.O. and G.F.; software, R.S., A.B., A.R. and F.P.N.; formal analysis, A.B., P.R., F.P.N., P.N. and L.D.M.; investigation, P.R., R.S., S.C., I.P., D.M., A.R., S.A., G.I., M.O. and G.F.; data curation, F.P.N., P.R., A.B., L.D.M. and P.N.; writing—original draft preparation, F.P.N., A.B., P.N. and L.D.M.; writing—review and editing, F.P.N., P.R., A.B., L.D.M. and P.N.; visualization, F.P.N., P.R., R.S., S.C., A.B., I.P., D.M., A.R., S.A., G.I., M.O., G.F., L.D.M. and P.N.; supervision, A.B., F.P.N., L.D.M. and P.N. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by the European Union e Next Generation EU, PROGETTI DI RICERCA DI RILEVANTE INTERESSE NAZIONALE (PRIN 2022)—Occurrence and molecular analysis of methicillin-resistant Staphylococci in cats and dogs: comparison between two Veterinary teaching Hospitals in Northern and Southern Italy. Project number: 2022TF32AL.

Institutional Review Board Statement

This study was approved by the Veterinary Service Center of the University of Naples Federico II (certificate number PG/2023/01203795, 5 October 2023) and by Bioethics Committee of the University of Turin (certificate number 0251347, 1 February 2024), in compliance with the Italian Legislative Decree 26/2014, Article 2 by implementing Directive 2010/63/EU. Nasal swab samples were collected from client-owned dogs undergoing routine surgical procedures at two Italian Veterinary Teaching Hospitals (University of Naples Federico II and University of Turin). Sample collection was performed by licensed veterinarians prior to surgery as part of standard clinical handling, causing minimal discomfort and no additional risk to the animals. In accordance with the Declaration of Helsinki (1975, revised in 2013), nasal swab samples from dog owners were self-collected following written instructions provided by study personnel at the participating Italian universities and under supervision. No invasive procedures were performed, and sample collection did not involve any additional risk to the participants beyond routine personal hygiene practices.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data supporting the findings of this study are available within this article.

Acknowledgments

This study was funded by the European Union e Next Generation EU, PROGETTI DI RICERCA DI RILEVANTE INTERESSE NAZIONALE (PRIN 2022)—Occurrence and molecular analysis of methicillin-resistant Staphylococci in cats and dogs: comparison between two Veterinary teaching Hospitals in North and South Italy. Project number: 2022TF32AL. The authors thank the clinical staff of the participating Veterinary Teaching Hospitals for their support during sample collection. We are grateful to the dog owners for their participation. The authors also acknowledge the SUS-MIRRI.IT (http://sus-mirri.it/, accessed on 15 January 2026) project for providing access to bacterial strains from the TUCC collection.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Ito, Y.; Nagasawa, M.; Koyama, K.; Ito, K.; Kikusui, T. Comparative analysis based on shared amplicon sequence variants reveals that cohabitation influences gut microbiota sharing between humans and dogs. Front. Vet. Sci. 2024, 11, 1417461. [Google Scholar] [CrossRef]
  2. Clougher, S.B.; Miorelli, C.; Astolfi, A.; Zaghi, A.; Scagliarini, A.; Versura, P. Pets in the household increase ocular surface microbiome exchanges between dog and owner. One Health 2025, 20, 101044. [Google Scholar] [CrossRef] [PubMed]
  3. Genath, A.; Hackmann, C.; Denkel, L.; Weber, A.; Maechler, F.; Kola, A.; Schwarz, S.; Gastmeier, P.; Leistner, R. The genetic relationship between human and pet isolates: A core genome multilocus sequence analysis of multidrug-resistant bacteria. Antimicrob. Resist. Infect. Control 2024, 13, 107. [Google Scholar] [PubMed]
  4. Zhou, N.; Chen, W.; Xia, L.; Li, M.; Ye, H.; Lv, C.; Chen, Y.; Cheng, Z.; Park, T.J.; Ho, P.L.; et al. Metagenomic insights into the resistome, mobilome, and virulome of dogs with diverse lifestyles. Anim. Microbiome 2024, 6, 76. [Google Scholar] [CrossRef] [PubMed]
  5. Misic, A.M.; Davis, M.F.; Tyldsley, A.S.; Hodkinson, B.P.; Tolomeo, P.; Hu, B.; Nachamkin, I.; Lautenbach, E.; Morris, D.O.; Grice, E.A. The shared microbiota of humans and companion animals as evaluated from Staphylococcus carriage sites. Microbiome 2015, 3, 2. [Google Scholar] [CrossRef]
  6. Jin, M.; Osman, M.; Green, B.A.; Yang, Y.; Ahuja, A.; Lu, Z.; Cazer, C.L. Evidence for the transmission of antimicrobial resistant bacteria between humans and companion animals: A scoping review. One Health 2023, 17, 100593. [Google Scholar] [CrossRef]
  7. Nocera, F.P.; Pizzano, F.; Masullo, A.; Cortese, L.; De Martino, L. Antimicrobial Resistant Staphylococcus Species Colonization in Dogs, Their Owners, and Veterinary Staff of the Veterinary Teaching Hospital of Naples, Italy. Pathogens 2023, 12, 1016. [Google Scholar] [CrossRef]
  8. Schmidt, V.M.; Williams, N.J.; Pinchbeck, G.; Corless, C.E.; Shaw, S.; McEwan, N.; Dawson, S.; Nuttall, T. Antimicrobial resistance and characterisation of staphylococci isolated from healthy Labrador retrievers in the United Kingdom. BMC Vet. Res. 2014, 10, 17. [Google Scholar]
  9. Hanselman, B.A.; Kruth, S.A.; Rousseau, J.; Weese, J.S. Coagulase positive staphylococcal colonization of humans and their household pets. Can. Vet. J. 2009, 50, 954–958. [Google Scholar]
  10. Chanchaithong, P.; Prapasarakul, N.; Perreten, V.; Schwendener, S. Characterization of a Novel Composite Staphylococcal Cassette Chromosome mec in Methicillin-Resistant Staphylococcus pseudintermedius from Thailand. Antimicrob. Agents Chemother. 2015, 60, 1153–1157. [Google Scholar] [CrossRef]
  11. Gómez-Sanz, E.; Torres, C.; Benito, D.; Lozano, C.; Zarazaga, M. Clonal relatedness of coagulase-positive staphylococci among healthy dogs and dog-owners in Spain. Front. Microbiol. 2023, 14, 1121564. [Google Scholar]
  12. Damborg, P.; Moodley, A.; Aalbæk, B.; Guardabassi, L. Colonization of methicillin-resistant Staphylococcus species in healthy and sick pets: Prevalence and risk factors. BMC Vet. Res. 2023, 19, 140. [Google Scholar]
  13. Guardabassi, L.; Larsen, J.; Weese, J.S.; Butaye, P.; Battisti, A.; Kluytmans, J.; Lloyd, D.H.; Skov, R.L. Public health risk of antimicrobial resistance transfer from companion animals. J. Antimicrob. Chemother. 2017, 72, 957–968. [Google Scholar]
  14. EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 15.0. 2025. Available online: http://www.eucast.org (accessed on 7 January 2025).
  15. Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multi-drug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef]
  16. Clinical and Laboratory Standards Institute (CLSI). VET01S, Performance Standards for Antimicrobial Disk and Dilution Susceptibility Test for Bacteria Isolate from Animals, 5th ed.; Clinical and Laboratory Standards Institute: Philadelphia, PA, USA, 2020. [Google Scholar]
  17. Stepanović, S.; Vuković, D.; Hola, V.; Di Bonaventura, G.; Djukić, S.; Cirković, I.; Ruzicka, F. Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007, 115, 891–899. [Google Scholar] [CrossRef]
  18. Nocera, F.P.; Chiaromonte, A.; Schena, R.; Pizzano, F.; Arslan, S.; Pedicini, C.; De Martino, L. Detection of Extend-ed-Spectrum β-Lactamases, Metallo-β-Lactamases, Antimicrobial Resistance Profiles, and Biofilm-Forming Capacity in Pseudomonas aeruginosa Strains Recovered from Dogs with Otitis Externa in Italy. Vet. Med. Int. 2025, 2025, 5566151. [Google Scholar] [CrossRef]
  19. R Core Team. A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2026; Available online: https://www.R-project.org/ (accessed on 12 January 2026).
  20. Becker, K.; Heilmann, C.; Peters, G. Coagulase-negative staphylococci. Clin. Microbiol. Rev. 2014, 27, 870–926. [Google Scholar] [CrossRef]
  21. Tong, S.Y.C.; Davis, J.S.; Eichenberger, E.; Holland, T.L.; Fowler, V.G. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015, 28, 603–661. [Google Scholar] [CrossRef]
  22. World Health Organization. WHO. One Health. 2017. Available online: https://www.who.int/health-topics/one-health#tab=tab_1 (accessed on 2 February 2023).
  23. Abdullahi, I.N.; Zarazaga, M.; Campaña-Burguet, A.; Eguizábal, P.; Lozano, C.; Torres, C. Nasal Staphylococcus aureus and S. pseudintermedius carriage in healthy dogs and cats: A systematic review of their antibiotic resistance, virulence and genetic lineages of zoonotic relevance. J. Appl. Microbiol. 2022, 133, 3368–3390. [Google Scholar] [CrossRef]
  24. Liu, Q.; Liu, Q.; Meng, H.; Lv, H.; Liu, Y.; Liu, J.; Wang, H.; He, L.; Qin, J.; Wang, Y.; et al. Staphylococcus epidermidis contributes to healthy maturation of the nasal microbiome by stimulating antimicrobial peptide production. Cell Host Microbe 2020, 27, 68–78.e5. [Google Scholar] [CrossRef]
  25. Sakr, A.; Brégeon, F.; Mège, J.-L.; Rolain, J.-M.; Blin, O. Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections. Front. Microbiol. 2018, 9, 2419. [Google Scholar] [CrossRef] [PubMed]
  26. Otto, M. Staphylococcus epidermidis—The ‘accidental’ pathogen. Nat. Rev. Microbiol. 2009, 7, 555–567. [Google Scholar] [CrossRef] [PubMed]
  27. Turner, N.A.; Sharma-Kuinkel, B.K.; Maskarinec, S.A.; Eichenberger, E.M.; Shah, P.P.; Carugati, M.; Holland, T.L.; Fowler, V.G. Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nat. Rev. Microbiol. 2019, 17, 203–218. [Google Scholar] [CrossRef] [PubMed]
  28. Cuny, C.; Layer-Nicolaou, F.; Weber, R.; Köck, R.; Witte, W. Colonization of Dogs and Their Owners with Staphylococcus aureus and Staphylococcus pseudintermedius in Households, Veterinary Practices, and Healthcare Facilities. Microorganisms 2022, 10, 677. [Google Scholar] [CrossRef]
  29. Simou, C.; Hill, P.B.; Forsythe, P.J.; Thoday, K.L. Species specificity in the adherence of staphylococci to canine and human corneocytes: A preliminary study. Vet. Dermatol. 2005, 16, 156–161. [Google Scholar] [CrossRef]
  30. Boost, M.V.; O’Donoghue, M.M.; James, A. Prevalence of Staphylococcus aureus carriage among dogs and their owners. Epidemiol. Infect. 2008, 136, 953–964. [Google Scholar] [CrossRef]
  31. Foster, T.J.; Geoghegan, J.A.; Ganesh, V.K.; Höök, M. Adhesion, invasion and evasion: The many functions of the surface proteins of Staphylococcus aureus. Nat. Rev. Microbiol. 2014, 12, 49–62. [Google Scholar] [CrossRef]
  32. Archer, N.K.; Mazaitis, M.J.; Costerton, J.W.; Leid, J.G.; Powers, M.E.; Shirtliff, M.E. Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease. Virulence 2011, 2, 445–459. [Google Scholar] [CrossRef]
  33. Kaushik, A.; Kest, H.; Sood, M.; Steussy, B.W.; Thieman, C.; Gupta, S. Biofilm Producing Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Humans: Clinical Implications and Management. Pathogens 2024, 13, 76. [Google Scholar] [CrossRef]
  34. Bhattacharya, M. The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections. FEMS Microbiol. Rev. 2024, 48, fuae002. [Google Scholar] [CrossRef]
  35. Lebeaux, D.; Chauhan, A.; Rendueles, O.; Beloin, C. From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens 2013, 2, 288–356. [Google Scholar] [CrossRef]
  36. Singh, S.; Singh, S.K.; Chowdhury, I.; Singh, R. Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. Open Microbiol. J. 2017, 11, 53–62. [Google Scholar] [CrossRef]
  37. Yu, J.; Han, W.; Xu, Y.; Shen, L.; Zhao, H.; Zhang, J.; Xiao, Y.; Guo, Y.; Yu, F. Biofilm-producing ability of methicillin-resistant Staphylococcus aureus clinically isolated in China. BMC Microbiol. 2024, 24, 241. [Google Scholar] [CrossRef]
  38. Bakeer, W.; Gaafar, M.; El-Gendy, A.O.; El Badry, M.A.; Khalil, M.G.; Mansour, A.T.; Alharbi, N.K.; Selim, H.M.R.M.; Bendary, M.M. Proven anti-virulence therapies in combating methicillin- and vancomycin-resistant Staphylococcus aureus infections. Front. Cell. Infect. Microbiol. 2024, 14, 1403219. [Google Scholar] [CrossRef] [PubMed]
  39. Carcione, D.; Leccese, G.; Conte, G.; Rossi, E.; Intra, J.; Bonomi, A.; Sabella, S.; Moreo, M.; Landini, P.; Brilli, M.; et al. Lack of Direct Correlation between Biofilm Formation and Antimicrobial Resistance in Clinical Staphylococcus epidermidis Isolates from an Italian Hospital. Microorganisms 2022, 10, 1163. [Google Scholar] [CrossRef]
  40. Donadu, M.G.; Ferrari, M.; Mazzarello, V.; Zanetti, S.; Kushkevych, I.; Rittmann, S.K.R.; Stájer, A.; Baráth, Z.; Szabó, D.; Urbán, E.; et al. No Correlation between Biofilm-Forming Capacity and Antibiotic Resistance in Environmental Staphylococcus spp.: In Vitro Results. Pathogens 2022, 11, 471. [Google Scholar] [CrossRef] [PubMed]
  41. Senobar Tahaei, S.A.; Stájer, A.; Barrak, I.; Ostorházi, E.; Szabó, D.; Gajdács, M. Correlation Between Biofilm-Formation and the Antibiotic Resistant Phenotype in Staphylococcus aureus Isolates: A Laboratory-Based Study in Hungary and a Review of the Literature. Infect. Drug Resist. 2021, 14, 1155–1168. [Google Scholar] [CrossRef] [PubMed]
  42. Madduri, A.; Vanommeslaeghe, L.; Coenye, T. Is Increased Biofilm Formation Associated with Decreased Antimicrobial Susceptibility? A Systematic Literature Review. Microorganisms 2025, 13, 2292. [Google Scholar] [CrossRef]
Figure 1. Antimicrobial resistance profiles of Staphylococcus spp. strains isolated from 12 dog–owner pairs in VTH1. MRS: methicillin-resistant staphylococci; P: penicillin; FA: fusidic acid; RD: rifampicin; CIP: ciprofloxacin; CD: clindamycin; E: erythromycin; ENR: enrofloxacin; CN: gentamicin; C: chloramphenicol; SXT: sulfamethoxazole–trimethoprim; TE: tetracycline; LNZ: linezolid.
Figure 1. Antimicrobial resistance profiles of Staphylococcus spp. strains isolated from 12 dog–owner pairs in VTH1. MRS: methicillin-resistant staphylococci; P: penicillin; FA: fusidic acid; RD: rifampicin; CIP: ciprofloxacin; CD: clindamycin; E: erythromycin; ENR: enrofloxacin; CN: gentamicin; C: chloramphenicol; SXT: sulfamethoxazole–trimethoprim; TE: tetracycline; LNZ: linezolid.
Pathogens 15 00356 g001
Figure 2. Antimicrobial resistance profiles of Staphylococcus spp. strains isolated from 42 dog–owner pairs in VTH2. MRS: methicillin-resistant staphylococci; P: penicillin; FA: fusidic acid; RD: rifampicin; CIP: ciprofloxacin; CD: clindamycin; E: erythromycin; ENR: enrofloxacin; CN: gentamicin; C: chloramphenicol; SXT: sulfamethoxazole–trimethoprim; TE: tetracycline; LNZ: linezolid.
Figure 2. Antimicrobial resistance profiles of Staphylococcus spp. strains isolated from 42 dog–owner pairs in VTH2. MRS: methicillin-resistant staphylococci; P: penicillin; FA: fusidic acid; RD: rifampicin; CIP: ciprofloxacin; CD: clindamycin; E: erythromycin; ENR: enrofloxacin; CN: gentamicin; C: chloramphenicol; SXT: sulfamethoxazole–trimethoprim; TE: tetracycline; LNZ: linezolid.
Pathogens 15 00356 g002
Figure 3. Biofilm-forming ability of Staphylococcus spp. strains isolated from 12 dog–owner pairs in Naples. Biofilm production ability was determined using the mean OD 570 nm of the negative control (0.05), represented by Brain Heart Infusion (BHI) broth. Values < 0.05 were considered non-biofilm producers; values between 0.05 and 0.1 (2× the negative control value of 0.05) were considered weak producers; values between 0.1 and 0.2 (4× the negative control value of 0.05) were considered moderate producers; values > 0.2 (>4× the negative control value of 0.05) were considered strong producers.
Figure 3. Biofilm-forming ability of Staphylococcus spp. strains isolated from 12 dog–owner pairs in Naples. Biofilm production ability was determined using the mean OD 570 nm of the negative control (0.05), represented by Brain Heart Infusion (BHI) broth. Values < 0.05 were considered non-biofilm producers; values between 0.05 and 0.1 (2× the negative control value of 0.05) were considered weak producers; values between 0.1 and 0.2 (4× the negative control value of 0.05) were considered moderate producers; values > 0.2 (>4× the negative control value of 0.05) were considered strong producers.
Pathogens 15 00356 g003
Figure 4. Biofilm-forming ability of Staphylococcus spp. strains isolated from 42 dog–owner pairs in Turin. Biofilm production ability was determined using the mean OD 570 nm of the negative control (0.05), represented by Brain Heart Infusion (BHI) broth. Values < 0.05 were considered non-biofilm producers; values between 0.05 and 0.1 (2× the negative control value of 0.05) were considered weak producers; values between 0.1 and 0.2 (4× the negative control value of 0.05) were considered moderate producers; values > 0.2 (>4× the negative control value of 0.05) were considered strong producers.
Figure 4. Biofilm-forming ability of Staphylococcus spp. strains isolated from 42 dog–owner pairs in Turin. Biofilm production ability was determined using the mean OD 570 nm of the negative control (0.05), represented by Brain Heart Infusion (BHI) broth. Values < 0.05 were considered non-biofilm producers; values between 0.05 and 0.1 (2× the negative control value of 0.05) were considered weak producers; values between 0.1 and 0.2 (4× the negative control value of 0.05) were considered moderate producers; values > 0.2 (>4× the negative control value of 0.05) were considered strong producers.
Pathogens 15 00356 g004
Table 1. Demographic, lifestyle, and clinical characteristics of dog–owner pairs from two Italian Veterinary Teaching Hospitals (VTHs).
Table 1. Demographic, lifestyle, and clinical characteristics of dog–owner pairs from two Italian Veterinary Teaching Hospitals (VTHs).
VariableCategoryVTH1 n. (%)VTH2 n. (%)Fisher’s Test pAdjusted p
SECTION A: LIFESTYLE AND MANAGEMENT
Living
environment
home68 (56.7%)80 (50.0%)0.2790.470
garden 12 (10.0%)3 (1.9%)0.0050.023
both 40 (33.3%)77 (48.1%)0.0150.048
Daily habitspersonal resting place10 (8.3%)13 (8.1%)1.0001.000
access to bed and sofa48 (40.0%)45 (28.1%)0.0410.109
resting place, bed, sofa62 (51.7%)102 (63.4%)0.0500.123
Parasite TreatmentNo administration0 (0.0%)9 (5.8%)0.0120.043
flea and tick control130 (87.8%)97 (63.0%)0.0120.043
with repellents30 (20.2%)47 (30.5%)0.4990.694
only repellents0 (0.0%)1 (0.7%)1.0001.000
constant use102 (68.9%)33 (23.2%)<0.001<0.001
intermittent use22 (14.9%)2 (1.4%)<0.001<0.001
monthly use26 (17.6%)11 (7.7%)0.0010.003
seasonal use21 (14.1%)96 (67.6%)<0.001<0.001
Feeding habitshomemade diet15 (12.5%)16 (10.0%)0.5660.755
commercial diet65 (54.2%)99 (61.9%)0.2280.429
mixed diet40 (33.3%)45 (28.1%)0.3610.550
SECTION B: PET-OWNER INTERACTION AND HYGIENE PRACTICES
Pet-owner
interaction
cuddles10 (8.3%)14 (8.8%)1.0001.000
cuddles, hugs20 (16.7%)18 (11.2%)0.2190.429
cuddles, hugs, kisses90 (75.0%)128 (80.0%)0.3830.527
Hand washing
after pet contact
always23 (19.2%)33 (20.6%)0.8801.000
sometimes79 (65.8%)103 (64.4%)0.8991.000
never18 (15.0%)24 (15.0%)1.0001.000
Interaction time
with pets
all day45 (37.5%)71 (44.4%)0.2710.470
half day59 (49.2%)60 (37.5%)0.0670.153
evening only16 (13.3%)29 (18.1%)0.3260.522
SECTION C: ANTIBIOTIC USE HISTORY
Antibiotic therapy
in pets
never0 (0.0%)26 (16.2%)<0.001<0.001
recent, e.g., last month36 (30.0%)63 (39.4%)0.1300.277
past, e.g., last year84 (70.0%)71 (44.4%)<0.001<0.001
Antibiotic therapy
in owners
never0 (0.0%)6 (3.8%)0.0390.109
recent, e.g., last month25 (20.8%)29 (18.1%)0.6470.828
past, e.g., last year95 (79.2%)125 (78.1%)0.8841.000
Significant p-values (p < 0.05; p < 0.001) are highlighted in bold.
Table 2. Distribution of Staphylococcus species isolated from nasal swabs of dogs and their owners at two Italian Veterinary Teaching Hospitals (VTHs).
Table 2. Distribution of Staphylococcus species isolated from nasal swabs of dogs and their owners at two Italian Veterinary Teaching Hospitals (VTHs).
Staphylococcus
Species
Total
n. (%)
VTH1 Dogs
n. (%)
VTH2 Dogs
n. (%)
VTH1 Owners
n. (%)
VTH2 Owners
n. (%)
S. epidermidis142 (29.8)7 (9.6)8 (6.2)53 (61.6)74 (39.4)
S. aureus106 (22.2)12 (16.4)21 (16.2)27 (31.4)46 (24.5)
S. pseudintermedius61 (12.8)26 (35.6)31 (23.8)0 (0.0)4 (2.1)
S. capitis33 (6.9)3 (4.1)14 (10.8)0 (0.0)16 (8.5)
S. warneri30 (6.3)4 (5.5)7 (5.4)2 (2.3)17 (9.0)
S. intermedius22 (4.6)2 (2.7)15 (11.5)0 (0.0)5 (2.7)
S. haemolyticus18 (3.8)3 (4.1)6 (4.6)0 (0.0)9 (4.8)
S. hominis11 (2.3)1 (1.4)7 (5.4)1 (1.2)2 (1.1)
S. xylosus10 (2.1)2 (2.7)5 (3.8)0 (0.0)3 (1.6)
S. lugdunensis9 (1.9)0 (0.0)0 (0.0)2 (2.3)7 (3.7)
S. felis5 (1.0)4 (5.5)1 (0.8)0 (0.0)0 (0.0)
S. simulans5 (1.0)4 (5.5)0 (0.0)1 (1.2)0 (0.0)
S. saprophyticus5 (1.0)0 (0.0)2 (1.5)0 (0.0)3 (1.6)
Other species §20 (4.2)5 (6.8)13 (10.0)0 (0.0)2 (1.1)
Total4777313086188
§ Other species include: S. equorum, S. nepalensis, S. lentus, S. schleiferi, S. coagulans, S. caprae, S. cohnii, S. condimenti, S. pasteuri, S. sciuri, and S. ureolyticus (each ≤ 1.0% per group).
Table 3. (a) Phenotypic characteristics of Staphylococcus isolates recovered from 12 dog–owner pairs in Naples (n = 24 isolates). (b) Phenotypic characteristics of Staphylococcus isolates recovered from 42 dog–owner pairs in Turin (n = 84 isolates).
Table 3. (a) Phenotypic characteristics of Staphylococcus isolates recovered from 12 dog–owner pairs in Naples (n = 24 isolates). (b) Phenotypic characteristics of Staphylococcus isolates recovered from 42 dog–owner pairs in Turin (n = 84 isolates).
(a)
PhenotypeDogs n. (%)Owners n. (%)Fisher’s Exact pAdjusted p
Penicillinase production9/12 (75%)10/12 (83.3%)1.0001.000
Methicillin resistance (MRS)5/12 (41.7%)6/12 (50%)1.0001.000
Multidrug resistance (MDR)5/12 (41.7%)8/12 (66.7%)0.4140.797
Biofilm-forming ability:
Weak02/12 (16.7%)0.4780.797
Moderate12/12 (100%)10/12 (83.3%)0.4780.797
Strong00-
Non-producer00-
(b)
PhenotypeDogs n. (%)Owners n. (%)Fisher’s exact pAdjusted p
Penicillinase production31/42 (73.8%)32/42 (76.2%)1.0001.000
Methicillin resistance (MRS)6/42 (14.3%)8/42 (19%)0.7711.000
Multidrug resistance (MDR)11/42 (26.2%)13/42 (31%)0.8101.000
Biofilm-forming ability:
Weak1/42 (2.4%)01.0001.000
Moderate27/42 (64.3%)23/42 (54.8%)0.5051.000
Strong14/42 (33.3%)19/42 (45.2%)0.3721.000
Non-producer00
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nocera, F.P.; Robino, P.; Schena, R.; Cavalli, S.; Bellato, A.; Prandi, I.; Mancusi, D.; Romano, A.; Arslan, S.; Iamone, G.; et al. Investigating the Sharing of Staphylococcus spp. Between Dogs and Their Owners: A Comparative Study from Two Italian Veterinary Teaching Hospitals. Pathogens 2026, 15, 356. https://doi.org/10.3390/pathogens15040356

AMA Style

Nocera FP, Robino P, Schena R, Cavalli S, Bellato A, Prandi I, Mancusi D, Romano A, Arslan S, Iamone G, et al. Investigating the Sharing of Staphylococcus spp. Between Dogs and Their Owners: A Comparative Study from Two Italian Veterinary Teaching Hospitals. Pathogens. 2026; 15(4):356. https://doi.org/10.3390/pathogens15040356

Chicago/Turabian Style

Nocera, Francesca Paola, Patrizia Robino, Rossana Schena, Stefano Cavalli, Alessandro Bellato, Ilaria Prandi, Davide Mancusi, Annunziata Romano, Sinem Arslan, Giulia Iamone, and et al. 2026. "Investigating the Sharing of Staphylococcus spp. Between Dogs and Their Owners: A Comparative Study from Two Italian Veterinary Teaching Hospitals" Pathogens 15, no. 4: 356. https://doi.org/10.3390/pathogens15040356

APA Style

Nocera, F. P., Robino, P., Schena, R., Cavalli, S., Bellato, A., Prandi, I., Mancusi, D., Romano, A., Arslan, S., Iamone, G., Olimpo, M., Fatone, G., De Martino, L., & Nebbia, P. (2026). Investigating the Sharing of Staphylococcus spp. Between Dogs and Their Owners: A Comparative Study from Two Italian Veterinary Teaching Hospitals. Pathogens, 15(4), 356. https://doi.org/10.3390/pathogens15040356

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop